Clinical Trial Detail

NCT ID NCT00940381
Title Sirolimus and Cetuximab in Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

colorectal cancer

Therapies

Cetuximab + Sirolimus

Age Groups: senior adult

No variant requirements are available.